You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 2, July 12, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  The World in Medicine
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Public Health Meets the Streets

Rebecca Voelker

JAMA. 2000;284:169.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A door-to-door education campaign in New Zealand appears to have been effective in raising public awareness about the severity of meningococcal disease.

Since 1991, the island nation has been in the grip of a serogroup B meningococcal disease epidemic that has disproportiontely affected children from Pacific Islander and Maori families. The disease rate in Pacific Island children is nearly 10 times that in European children.

The education program, directed by the Auckland Public Health Department, dispatched trained lay educators to more than 11,000 homes in high-risk communities in Auckland in 1998. Lay educators received training in how to describe rapidly advancing symptoms that include high fever, headache, stiff neck, nausea, and confusion.

Public health officials later sent an evaluation survey to 300 Auckland households, half of which lay educators had visited. In the June issue of Health Education & Behavior, they reported that 99% of the residents . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors
Colonno et al.
Antimicrob. Agents Chemother. 2003;47:1324-1333.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.